EVALUATION OF PARENTERAL ANTICOAGULANTS USE IN COVID-19 PATIENTS AT A HOSPITAL IN SIAK DISTRICT
COVID-19 can trigger a cytokine storm and systemic hyper inflammation leading to increased activation of coagulation and resulting in hypercoagulability. The hypercoagulable state in COVID-19 patients increases the risk of thrombosis and thromboembolism. Parenteral anticoagulants are used for thr...
Saved in:
Main Author: | Anggraeni, Silvana |
---|---|
Format: | Theses |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/65761 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Similar Items
-
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients
by: Cuker A.
Published: (2023) -
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19
by: Adam Cuker, et al.
Published: (2022) -
Pragmatic recommendations for the management of anticoagulation and venous thrombotic disease for hospitalized patients with COVID-19 in low- And middle-income countries
by: Hanan Y. Ahmed, et al.
Published: (2022) -
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients
by: Adam Cuker, et al.
Published: (2022) -
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients
by: Cuker A.
Published: (2023)